Rodriguez-Porcel, Federico; Wyman-Chick, Kathryn A; Abdelnour Ruiz, Carla; Toledo, Jon B; Ferreira, Daniel; Urwyler, Prabitha; Weil, Rimona S; Kane, Joseph; Pilotto, Andrea; Rongve, Arvid; Boeve, Bradley; Taylor, John-Paul; McKeith, Ian; Aarsland, Dag; Lewis, Simon J G (2022). Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations. Translational neurodegeneration, 11(1), p. 24. BioMed Central 10.1186/s40035-022-00299-w
|
Text
s40035-022-00299-w.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (871kB) | Preview |
The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit in clinical trials often relies on tools developed for other conditions, such as Alzheimer's or Parkinson's disease. These may not be sufficiently valid or sensitive to treatment changes in DLB, decreasing their utility. In this review, we discuss the limitations and strengths of selected available tools used to measure DLB-associated outcomes in clinical trials and highlight the potential roles for more specific objective measures. We emphasize that the existing outcome measures require validation in the DLB population and that DLB-specific outcomes need to be developed. Finally, we highlight how the selection of outcome measures may vary between symptomatic and disease-modifying therapy trials.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
10 Strategic Research Centers > ARTORG Center for Biomedical Engineering Research > ARTORG Center - Gerontechnology and Rehabilitation |
UniBE Contributor: |
Urwyler-Harischandra, Prabitha |
ISSN: |
2047-9158 |
Publisher: |
BioMed Central |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
03 May 2022 10:16 |
Last Modified: |
05 Dec 2022 16:19 |
Publisher DOI: |
10.1186/s40035-022-00299-w |
PubMed ID: |
35491418 |
Uncontrolled Keywords: |
Clinical trials Dementia with Lewy bodies Measurement properties Outcomes |
BORIS DOI: |
10.48350/169699 |
URI: |
https://boris.unibe.ch/id/eprint/169699 |
Actions (login required)
 |
Edit item |